Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Accumulated Expenses (2016 - 2025)

Collegium Pharmaceutical has reported Other Accumulated Expenses over the past 11 years, most recently at $6.4 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 31.42% year-over-year to $6.4 million; the TTM value through Sep 2025 reached $6.4 million, up 31.42%, while the annual FY2024 figure was $4.8 million, 32.17% up from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $6.4 million at Collegium Pharmaceutical, up from $4.3 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $6.4 million in Q3 2025 and troughed at $578000.0 in Q1 2021.
  • A 5-year average of $3.4 million and a median of $3.4 million in 2022 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: tumbled 63.74% in 2021 and later skyrocketed 816.61% in 2022.
  • Year by year, Other Accumulated Expenses stood at $2.8 million in 2021, then increased by 21.28% to $3.4 million in 2022, then grew by 4.41% to $3.6 million in 2023, then soared by 32.17% to $4.8 million in 2024, then skyrocketed by 33.98% to $6.4 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for COLL at $6.4 million in Q3 2025, $4.3 million in Q2 2025, and $4.8 million in Q1 2025.